Cited by 505Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesMeta-analysis and systematic reviews

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Open access

Kent, David M, Rothwell, Peter M, Ioannidis, John PA, Altman, Doug G, Hayward, Rodney A·2010·Trials

DOI 10.1186/1745-6215-11-85PMC PMC2928211

Open this paper in CoChat — free account Open PDF

Abstract

Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance between treatment risks and benefits may differ substantially between large identifiable patient subgroups; the "average" benefit observed in the summary result may even be non-representative of the treatment effect for a typical patient in the trial. Conventional subgroup analyses, which examine whether specific patient characteristics modify the effects of treatment, are usually unable to detect even large variations in treatment benefit (and harm) across risk groups because they do not account for the fact that patients have multiple characteristics simultaneously that affect the likelihood of treatment benefit. Based upon recent evidence on optimal statistical approaches to assessing HTE, we propose a framework that prioritizes the analysis and reporting of multivariate risk-based HTE and suggests that other subgroup analyses should be explicitly labeled either as primary subgroup analyses (well-motivated by prior evidence and intended to produce clinically actionable results) or secondary (exploratory) subgroup analyses (performed to inform future research). A standardized and transparent approach to HTE assessment and reporting could substantially improve clinical trial utility and interpretability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/1745-6215-11-85

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Self-citation
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 1×
“Additionally, because conventional subgroup analyses involve multiple comparisons and involve splitting the overall sample to smaller sub-samples, they are both under-powered for detecting genuine subgroup effects (prone to false-negatives), and even more commonly they are prone to false positive findings [25-31].”
BackgroundSelf-citation
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
Antman, E. M., Cohen, M. C., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalán, R., Radley, D. R., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,221
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,168
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
Yusuf, S., Zucker, D. M., Passamani, E. R., Peduzzi, P. N., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K. B., Killip, T., Norris, R. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,125
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R. M., Frey, M. J., Lakkis, N. M., Neumann, F., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,093
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)04292-4 · Cited by 1,564

Show all 72 references

Sorted by citations

Items 101–200 of 505

Decision Curve Analysis for Personalized Treatment Choice between Multiple Options
Chalkou, K., Vickers, A. J., Pellegrini, F., Manca, A., & Salanti, G. (2022) · Medical Decision Making · doi:10.1177/0272989x221143058 · Cited by 49
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer
Carter, G. C., Barrett, A. M., Kaye, J. A., Liepa, A. M., Winfree, K. B., & John, W. J. (2014) · Cancer Management and Research · doi:10.2147/cmar.s63603 · Cited by 49
Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia ( BPH )
Kozminski, M. A., Wei, J. T., Nelson, J., & Kent, D. M. (2014) · British Journal of Urology · doi:10.1111/bju.12802 · Cited by 48
Self-citation
Lessons learned from the first wave of aging with HIV
Justice, A. C., & Braithwaite, R. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283558500 · Cited by 48
Clinical Value of Predicting Individual Treatment Effects for Intensive Blood Pressure Therapy: A Machine Learning Experiment to Estimate Treatment Effects from Randomized Trial Data [RETRACTED]
Duan, T., Rajpurkar, P., Laird, D., Ng, A. Y., & Basu, S. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005010 · Cited by 49
Retracted
Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions
Klaveren, D. V., Vergouwe, Y., Farooq, V., Serruys, P. W. J. C., & Steyerberg, E. W. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.02.012 · Cited by 51
How Well Do Randomized Trials Inform Decision Making: Systematic Review Using Comparative Effectiveness Research Measures on Acupuncture for Back Pain
Witt, C. M., Manheimer, E. W., Hammerschlag, R., Lüdtke, R., Lao, L., Tunis, S., & Berman, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032399 · Cited by 47
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial
Bayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J. D., Green, A. R., Reeve, E., Weffald, L. A., Wright, L., Maciejewski, M. L., Sheehan, O. C., et al. (2020) · Trials · doi:10.1186/s13063-020-04482-0 · Cited by 47
Risk Models and Patient-Centered Evidence
Shah, N. D. (2012) · JAMA · doi:10.1001/jama.2012.469 · Cited by 46
Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department
Brown, M. D., Burton, J. H., Nazarian, D. J., Promes, S. B., Cantrill, S. V., Brown, M. D., Brecher, D., Diercks, D. B., Gemme, S. R., Gerardo, C. J., et al. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.06.031 · Cited by 46
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours
Rowland, A., Dias, M. M., Wiese, M. D., Kichenadasse, G., McKinnon, R. A., Karapetis, C. S., & Sorich, M. J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.025 · Cited by 46
Personalised medicine: not just in our genes
Kitsios, G. D., & Kent, D. M. (2012) · BMJ · doi:10.1136/bmj.e2161 · Cited by 45
Self-citation
Considerations when assessing heterogeneity of treatment effect in patient-centered outcomes research
Lesko, C. R., Henderson, N. C., & Varadhan, R. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.04.005 · Cited by 45
Tight Glycemic Control After Pediatric Cardiac Surgery in High-Risk Patient Populations
Agus, M. S. D., Asaro, L. A., Steil, G. M., Alexander, J. L., Silverman, M. R., Wypij, D., & Gaies, M. (2014) · Circulation · doi:10.1161/circulationaha.113.008124 · Cited by 44
The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings
Münter, K., Meaume, S., Augustin, M., Senet, P., & Kerihuel, J. (2017) · Journal of Wound Care · doi:10.12968/jowc.2017.26.sup2.s4 · Cited by 44
Patient-Centered Outcomes Research
(2017) · doi:10.25302/67.2017.1 · Cited by 44
Patient-Reported Outcomes in Clinical Trials of CKD-Related Therapies: Report of a Symposium Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Perrone, R. D., Coons, S. J., Cavanaugh, K. L., Finkelstein, F., & Meyer, K. B. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.07.004 · Cited by 43
Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care
O’Hare, A. M., Rodriguez, R. A., & Bowling, C. B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv003 · Cited by 43
Personalizing the Intensity of Blood Pressure Control
Patel, K., Arnold, S. V., Chan, P. S., Tang, Y., Pokharel, Y., Jones, P. G., & Spertus, J. A. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003624 · Cited by 43
Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
Santhakumaran, S., Gordon, A. C., Prevost, A. T., O’Kane, C. M., McAuley, D. F., & Shankar‐Hari, M. (2019) · Critical Care · doi:10.1186/s13054-019-2446-1 · Cited by 43
Covariate adjustment had similar benefits in small and large randomized controlled trials
Thompson, D. D., Lingsma, H. F., Whiteley, W. N., Murray, G. D., & Steyerberg, E. W. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.001 · Cited by 42
Impact of Telemonitoring on Health Status
Jayaram, N. M., Khariton, Y., Krumholz, H. M., Chaudhry, S. I., Mattera, J. A., Tang, F., Herrin, J. S., Hodshon, B., & Spertus, J. A. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.004148 · Cited by 42
Building causal knowledge in behavior genetics
Madole, J. W., & Harden, K. P. (2022) · Behavioral and Brain Sciences · doi:10.1017/s0140525x22000681 · Cited by 43
The Problem of Subgroup Analyses: An Example from a Trial on Ruptured Intracranial Aneurysms
Naggara, O. N., Raymond, J., Guilbert, F., & Altman, D. G. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2442 · Cited by 42
Self-citation
Counterfactual clinical prediction models could help to infer individualized treatment effects in randomized controlled trials—An illustration with the International Stroke Trial
Nguyen, T., Collins, P. G. S., Landais, P., & Manach, Y. L. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.05.022 · Cited by 43
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
the IST-3 collaborative group, Sandercock, P. A., Lindley, R. I., Wardlaw, J. M., Dennis, M. S., Innes, K., Cohen, G., Whiteley, W. N., Perry, D., Soosay, V., et al. (2011) · Trials · doi:10.1186/1745-6215-12-252 · Cited by 40
Using Real‐World Data to Extrapolate Evidence From Randomized Controlled Trials
Wang, S. V., Schneeweiß, S., Gagne, J. J., Evers, T., Gerlinger, C., Desai, R. J., & Najafzadeh, M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1210 · Cited by 40
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial
Fogel, E. L., Lehman, G. A., Tarnasky, P. R., Coté, G. A., Schmidt, S. E., Waljee, A. K., Higgins, P., Watkins, J. L., Sherman, S., Kwon, R. S., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30337-1 · Cited by 40
A randomized controlled trial of an intervention delivered by mobile phone text message to increase the acceptability of effective contraception among young women in Palestine
McCarthy, O., Zghayyer, H., Stavridis, A., Adada, S., Ahamed, I., Leurent, B., Edwards, P., Palmer, M. J., & Free, C. (2019) · Trials · doi:10.1186/s13063-019-3297-4 · Cited by 41
Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis
Royston, P. J., & Sauerbrei, W. (2014) · Statistics in Medicine · doi:10.1002/sim.6308 · Cited by 42
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals
Gabler, N. B., Duan, N., Raneses, E., Suttner, L. H., Ciarametaro, M., Cooney, E. L., Dubois, R. W., Halpern, S. D., & Kravitz, R. L. (2016) · Trials · doi:10.1186/s13063-016-1447-5 · Cited by 40
Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework
Potter, B. K., Chakraborty, P. K., Kronick, J. B., Wilson, K. R., Coyle, D., Feigenbaum, A. J., Geraghty, M. T., Karaceper, M. D., Little, J., Mhanni, A. A., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.153 · Cited by 38
Accuracy of the Spot Sign on Computed Tomography Angiography as a Predictor of Haematoma Enlargement after Acute Spontaneous Intracerebral Haemorrhage: A Systematic Review
Giudice, A. D., D'Amico, D., Sobesky, J., & Wellwood, I. (2014) · Cerebrovascular Diseases · doi:10.1159/000360754 · Cited by 37
Combinatorial Action of Temporally Segregated Transcription Factors
Charest, J., Daniele, T., Wang, J., Bykov, A., Mandlbauer, A., Asparuhova, M., Roehsner, J., Gutiérrez‐Pérez, P., & Cochella, L. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.002 · Cited by 37
Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation details
Nguyen, T. Q., Ackerman, B., Schmid, I. T., Cole, S. R., & Stuart, E. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208795 · Cited by 41
Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal
Abraira, V., Muriel, A., Emparanza, J. I., Pijoán, J. I., Royuela, A., Plana, N., Cano, A., Urreta, I., & Zamora, J. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.06.009 · Cited by 38
A randomized controlled trial of an intervention delivered by mobile phone app instant messaging to increase the acceptability of effective contraception among young people in Tajikistan
McCarthy, O., Ahamed, I., Kulaeva, F., Tokhirov, R., Saibov, S., Vandewiele, M., Standaert, S., Leurent, B., Edwards, P., Palmer, M. J., et al. (2018) · Reproductive Health · doi:10.1186/s12978-018-0473-z · Cited by 36
Assessing Heterogeneity of Treatment Effect in Real-World Data
Segal, J. B., Varadhan, R., Groenwold, R. H. H., Henderson, N., Li, X., Nomura, K., Kaplan, S., Ardeshir‐Rouhani‐Fard, S., Heyward, J., Nyberg, F., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-1510 · Cited by 37
Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study
Wang, S. V., Franklin, J. M., Glynn, R. J., Schneeweiß, S., Eddings, W., & Gagne, J. J. (2016) · BMJ · doi:10.1136/bmj.i2607 · Cited by 35
A CTSA Agenda to Advance Methods for Comparative Effectiveness Research
Helfand, M., Tunis, S., Whitlock, E. P., Pauker, S. G., Basu, A., Chilingerian, J. A., Harrell, F. E., Meltzer, D., Montori, V. M., Shepard, D. S., et al. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00282.x · Cited by 34
Self-citation
Multimorbidity in randomized controlled trials of behavioral interventions: A systematic review.
Stoll, C. R. T., Izadi, S. R., Fowler, S. A., Philpott-Streiff, S. E., Green, P. A., Suls, J. M., Winter, A. C., & Colditz, G. A. (2019) · Health Psychology · doi:10.1037/hea0000726 · Cited by 34
Pre-Clinical Common Data Elements for Traumatic Brain Injury Research: Progress and Use Cases
LaPlaca, M. C., Huie, J. R., Alam, H. B., Bachstetter, A. D., Bayır, H., Bellgowan, P. S. F., Cummings, D. M., Dixon, C. E., Ferguson, A. R., Ferland‐Beckham, C., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7328 · Cited by 34
The PCORI Methodology Report
Newhouse, R. P. (2017) · doi:10.25302/67.2017 · Cited by 34
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
Selker, H. P., Oye, K. A., Hg, E., Stockbridge, N., Mehta, C. R., Kaitin, K. I., McElwee, N. E., Honig, P. K., Erban, J. K., & D’Agostino, R. B. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.177 · Cited by 33
Individual and Population Benefits of Daily Aspirin Therapy
Sussman, J. B., Vijan, S. S., Choi, H., & Hayward, R. A. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959239 · Cited by 33
Self-citation
Nursing research in heart failure care: a position statement of the american association of heart failure nurses (AAHFN)
Stamp, K. D., Prasun, M. A., Lee, C. S., Jaarsma, T., Piano, M. R., & Albert, N. M. (2018) · Heart & Lung · doi:10.1016/j.hrtlng.2018.01.003 · Cited by 33
Design and estimation in clinical trials with subpopulation selection
Chiu, Y., König, F., Posch, M., & Jaki, T. (2018) · Statistics in Medicine · doi:10.1002/sim.7925 · Cited by 33
Mediators, Moderators, and Covariates: Matching Analysis Approach for Improved Precision in Cognitive-Communication Rehabilitation Research
Morrow, E. L., Duff, M. C., & Mayberry, L. S. (2022) · Journal of Speech Language and Hearing Research · doi:10.1044/2022_jslhr-21-00551 · Cited by 33
Using observational data for personalized medicine when clinical trial evidence is limited
Gershman, B., Guo, D. P., & Dahabreh, I. J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.005 · Cited by 33
Patient Perceptions of Their Own Data in mHealth Technology–Enabled N-of-1 Trials for Chronic Pain: Qualitative Study
Whitney, R. L., Ward, D., Marois, M., Schmid, C. H., Sim, I., & Kravitz, R. L. (2018) · JMIR mhealth and uhealth · doi:10.2196/10291 · Cited by 32
Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial
Rysavy, M. A., Li, L., Tyson, J. E., Jensen, E. A., Das, A., Ambalavanan, N., Laughon, M. M., Greenberg, R. G., Patel, R. M., Pedroza, C., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.05.022 · Cited by 32
A two‐stage prediction model for heterogeneous effects of treatments
Chalkou, K., Steyerberg, E. W., Egger, M., Manca, A., Pellegrini, F., & Salanti, G. (2021) · Statistics in Medicine · doi:10.1002/sim.9034 · Cited by 32
Guidelines for the Older Adult With CKD
Uhlig, K., & Boyd, C. M. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.001 · Cited by 32
Barriers and Facilitators of Evidence-Based Psychotherapies for Chronic Pain in Adults: A Systematic Review
Goldsmith, E. S., Miller, W., Koffel, E., Ullman, K. E., Landsteiner, A. M. K., STROEBEL, B. M., Hill, J., Ackland, P. E., Wilt, T. J., & Duan‐Porter, W. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.02.026 · Cited by 33
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Ruscitti, P., Allanore, Y., Baldini, C., Barilaro, G., Bocci, E. B., Bearzi, P., Bellis, E., Berardicurti, O., Biaggi, A., Bombardieri, M., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103581 · Cited by 31
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease
Qintar, M., Humphries, K. H., Park, J. E., Arnold, S. V., Tang, Y., Jones, P. G., Salisbury, A. C., Kureshi, F., Farkouh, M. E., Fuster, V., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.083 · Cited by 30
Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome
Salisbury, A. C., Wang, K., Cohen, D. J., Li, Y., Jones, P. G., & Spertus, J. A. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965624 · Cited by 29
The Value of Patient Registries to Advance Basic and Translational Research in the Area of Traumatic Brain Injury
Duff, M. C., Morrow, E. L., Edwards, M., McCurdy, R. A., Clough, S., Patel, N. N., Walsh, K., & Covington, N. V. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.846919 · Cited by 30
CHoosing Options for Insomnia in Cancer Effectively (CHOICE): Design of a patient centered comparative effectiveness trial of acupuncture and cognitive behavior therapy for insomnia
Garland, S. N., Gehrman, P., Barg, F. K., Xie, S. X., & Mao, J. J. J. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.02.010 · Cited by 29
The development of CHAMP: a checklist for the appraisal of moderators and predictors
van Hoorn, R., Tummers, M., Booth, A., Gerhardus, A., Rehfuess, E. A., Hind, D., Bossuyt, P. M., Welch, V. A., Debray, T. P. A., Underwood, M. R., et al. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0451-0 · Cited by 30
Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs
Shankar‐Hari, M., Santhakumaran, S., Prevost, A. T., Ward, J. K., Marshall, T. J., Bradley, C., Calfee, C. S., Delucchi, K., Sinha, P., Matthay, M. A., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08100 · Cited by 28
Assessing heterogeneity of treatment effect in a clinical trial with the proportional interactions model
Kovalchik, S. A., Varadhan, R., & Weiss, C. O. (2013) · Statistics in Medicine · doi:10.1002/sim.5881 · Cited by 29
Individualizing endpoints in randomized clinical trials to better inform individual patient care: the TARGET proposal
Iwashyna, T. J., & Deane, A. M. (2016) · Critical Care · doi:10.1186/s13054-016-1388-0 · Cited by 26
A Patient‐Centered Approach to Comparative Effectiveness Research Focused on Older Adults: Lessons From the Patient‐Centered Outcomes Research Institute
Mason, N. R., Sox, H. C., & Whitlock, E. P. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15655 · Cited by 28
Improving Veteran Access to Integrated Management of Back Pain (AIM-Back): Protocol for an Embedded Pragmatic Cluster-Randomized Trial
George, S. Z., Coffman, C. J., Allen, K. D., Lentz, T. A., Choate, A., Goode, A. P., Simon, C. B., Grubber, J. M., King, H. A., Cook, C. E., et al. (2020) · Pain Medicine · doi:10.1093/pm/pnaa348 · Cited by 26
Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus
van der Leeuw, J., Visseren, F. L. J., Woodward, M., Zoungas, S., Kengne, A. P., van der Graaf, Y., Glasziou, P., Hamet, P., MacMahon, S. W., Poulter, N. R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04421 · Cited by 26
Patient-centric HTA: different strokes for different folks
Mühlbacher, A. C. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2015.1038245 · Cited by 26
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease
Zhang, Z., Jones, P. G., Weintraub, W. S., Mancini, G. B. J., Sedlis, S. P., Maron, D. J., Teo, K. K., Hartigan, P. M., Kostuk, W. J., Berman, D. S., et al. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003971 · Cited by 26
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Palmer, D. H., Jackson, R., Springfeld, C., Ghaneh, P., Rawcliffe, C. L., Halloran, C. M., Faluyi, O. O., Cunningham, D., Wadsley, J., Darby, S., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.01118 · Cited by 25
Evidence generation and reproducibility in cell and gene therapy research: A call to action
Abou‐El‐Enein, M., Angelis, A., Appelbaum, F. R., Andrews, N. C., Bates, S. E., Bierman, A. S., Brenner, M. K., Cavazzana, M., Caligiuri, M. A., Clevers, H. C., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.06.012 · Cited by 26
Self-citation
Multiple Micronutrient Interventions Are Efficacious, but Research on Adequacy, Plausibility, and Implementation Needs Attention ,
Habicht, J., & Pelto, G. H. (2011) · Journal of Nutrition · doi:10.3945/jn.110.137158 · Cited by 25
Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely?
Davidoff, F. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1721 · Cited by 25
Graded exposure treatment for adolescents with chronic pain (GET Living): Protocol for a randomized controlled trial enhanced with single case experimental design
Simons, L. E., Harrison, L. E., O'Brien, S. F., Heirich, M. S., Loecher, N., Boothroyd, D. B., Vlaeyen, J. W. S., Wicksell, R. K., Schofield, D., Hood, K. K., et al. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100448 · Cited by 24
“due to heterogeneity in treatment effects [21].”
Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
Kernan, W. N., Viscoli, C. M., Dearborn, J. L., Kent, D. M., CONWIT, R. A., Fayad, P. B., Furie, K. L., Gorman, M., Guarino, P., Inzucchi, S. E., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2136 · Cited by 24
Self-citation
A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses
Schandelmaier, S., Chang, Y., Devasenapathy, N., Devji, T., Kwong, J. S. W., Colunga‐Lozano, L. E., Lee, Y., Agarwal, A., Bhatnagar, N., Ewald, H., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.05.014 · Cited by 24
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention
He, W., Xu, C., Wang, X., Lei, J., Qiu, Q., Hu, Y., & Luo, D. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02255-4 · Cited by 24
Towards assessing agricultural land suitability with causal machine learning
Giannarakis, G., Sitokonstantinou, V., Lorilla, R. S., & Kontoes, C. (2022) · IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW) · doi:10.1109/cvprw56347.2022.00150 · Cited by 24
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
Hanlon, P., Butterly, E. W., Shah, A. S. V., Hannigan, L. J., Lewsey, J., Mair, F. S., Kent, D. M., Guthrie, B., Wild, S. H., Welton, N. J., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004176 · Cited by 24
Self-citation
Approaches to Comparative Effectiveness Research in Multimorbid Populations
Maciejewski, M. L., & Bayliss, E. A. (2014) · Medical Care · doi:10.1097/mlr.0000000000000060 · Cited by 24
Patient Variability Seldom Assessed in Cost-effectiveness Studies
Lavelle, T. A., Kent, D. M., Lundquist, C. M., Thorat, T., Cohen, J. T., Wong, J. B., Olchanski, N., & Neumann, P. J. (2018) · Medical Decision Making · doi:10.1177/0272989x17746989 · Cited by 25
Self-citation
The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale, implications, and implementation
Jaspers, N. E. M., Ridker, P. M., Dorresteijn, J. A. N., & Visseren, F. L. J. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000554 · Cited by 25
Predicting response to a cognitive-behavioral approach to treating low back pain: Secondary analysis of the BeST data set
Underwood, M., Mistry, D., Lall, R., & Lamb, S. (2011) · Arthritis Care & Research · doi:10.1002/acr.20518 · Cited by 23
Development, evaluation and implementation of a digital behavioural health treatment for chronic pain: study protocol of the multiphase DAHLIA project
Bartels, S. L., Johnsson, S. I., Boersma, K., Flink, I., McCracken, L. M., Petersson, S., Christie, H. L., Feldman, I., Simons, L. E., Onghena, P., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059152 · Cited by 23
Identifying subgroups: Part 2: Trajectories of change over time
Lee, C. S., Faulkner, K. M., & Thompson, J. H. (2020) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515120911330 · Cited by 23
Long-Term Implications of Abnormal Left Ventricular Strain During Sepsis
Beesley, S. J., Sorensen, J., Walkey, A. J., Tonna, J. E., Lanspa, M. J., Hirshberg, E. L., Grissom, C. K., Horne, B. D., Burk, R. E., Abraham, T. P., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004886 · Cited by 23
Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial
Onófrio, F. D. Q., Lima, J. C. P., Watte, G., Lehmen, R. L., Oba, D., Camargo, G., & dos Santos, C. E. O. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-5234-x · Cited by 23
Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges
Oyama, M. A., Ellenberg, S. S., & Shaw, P. A. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14744 · Cited by 23
PCORI Methodology Standards
(2017) · doi:10.25302/67.2017.3 · Cited by 23
Conduct and Implementation of Personalized Trials in Research and Practice
Kravitz, R. L., & Duan, N. (2022) · Harvard Data Science Review · doi:10.1162/99608f92.901255e7 · Cited by 23
Limitations of Medical Research and Evidence at the Patient-Clinician Encounter Scale
Morris, A. H., & Ioannidis, J. P. A. (2013) · CHEST Journal · doi:10.1378/chest.12-1908 · Cited by 23
Self-citation
Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
Rigdon, J., Baiocchi, M., & Basu, S. (2018) · Trials · doi:10.1186/s13063-018-2774-5 · Cited by 22
Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine.
Alemayehu, D., & Cappelleri, J. C. (2012) · PubMed Central · Cited by 22
Overall average treatment effects from clinical trials, one-variable-at-a-time subgroup analyses and predictive approaches to heterogeneous treatment effects: Toward a more patient-centered evidence-based medicine
Kent, D. M. (2023) · Clinical Trials · doi:10.1177/17407745231171897 · Cited by 21
Self-citation
Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error
Holmes, C., & Watson, J. A. (2020) · Trials · doi:10.1186/s13063-020-4076-y · Cited by 23
Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model
Upshaw, J. N., Klaveren, D. V., Konstam, M. A., & Kent, D. M. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.010 · Cited by 20
Self-citation
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
Hilkens, N. A., Algra, A., Diener, H., Bath, P. M., Csiba, L., Hacke, W., Kappelle, L. J., Koudstaal, P. J., Leys, D., Mas, J., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031755 · Cited by 21
Medicina basada en la evidencia y medicina centrada en el paciente: algunas reflexiones sobre su integración
Sacristán, J. A. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.05.014 · Cited by 20
The “Dry-Run” Analysis: A Method for Evaluating Risk Scores for Confounding Control
Wyss, R., Hansen, B. B., Ellis, A. R., Gagne, J. J., Desai, R. J., Glynn, R. J., & Stürmer‎, T. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx032 · Cited by 20
Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach
Kleipool, E. E. F., Dorresteijn, J. A. N., Smulders, Y. M., Visseren, F. L. J., Peters, M. J. L., & Muller, M. (2019) · Heart · doi:10.1136/heartjnl-2019-315600 · Cited by 20
An Intervention Delivered by Mobile Phone Instant Messaging to Increase Acceptability and Use of Effective Contraception Among Young Women in Bolivia: Randomized Controlled Trial
McCarthy, O., Aliaga, C., Palacios, M. E. T., Gallardo, J. L., Huaynoca, S., Leurent, B., Edwards, P., Palmer, M. J., Ahamed, I., & Free, C. (2020) · Journal of Medical Internet Research · doi:10.2196/14073 · Cited by 23

Authors: Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A.
Affiliations: Tufts Medical Center (US)
John Radcliffe Hospital (GB)
University of Oxford (GB)
University of Michigan (US)
Corresponding author: Kent, David M
ORCID: Kent, David M
Rothwell, Peter M
Ioannidis, John PA
Hayward, Rodney A
Venue: Trials
Publisher: Springer Science and Business Media LLC
Published: 2010-08-12
Volume: 11
Issue: 1
Pages: 85-85
ISSN: 1745-6215 (ISSN-L)
DOI: 10.1186/1745-6215-11-85
PMC: PMC2928211
OpenAlex: W2128780239
Cited by: 504
References: 72
Citations by year: 2026: 32 · 2025: 20 · 2024: 33 · 2023: 26 · 2022: 25 · 2021: 43 · 2020: 32 · 2019: 42 · 2018: 36 · 2017: 37 · 2016: 41 · 2015: 31 · 2014: 39 · 2013: 15 · 2012: 28
FWCI: 17.70
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0 (tdm)
Locations: Trials (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Pfizer
National Institutes of Health (P60DK20572)
Quality Enhancement Research Initiative
National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020572, P60 DK 20572)
National Institute of Neurological Disorders and Stroke (R01NS062153)
National Center for Research Resources (U54 RR023562)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords: treatment effect heterogeneity, subgroup analysis, clinical trial reporting, treatment risks and benefits, risk stratification
MeSH terms: Clinical Trials as Topic, Humans, Risk Factors, Therapeutics, Reproducibility of Results, Multivariate Analysis, Risk Assessment, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks